Probiotix Health plc (PBX) ORD GBP0.05
0.70p
(10.37%)
- Add to watchlist
- This stock can be held in a
0.70p
(10.37%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.70p
(10.37%)
Business summary
ProBiotix Health plc is a United Kingdom-based life sciences company. The Company is engaged in the development of probiotics to tackle cardiovascular disease and other lifestyle conditions. Its principal product, Lactobacillus plantarum ECGC13110402 (LP-LDL), can reduce key cardiovascular risk biomarkers, such as total cholesterol, LDL (bad) cholesterol and blood pressure, by 36.7 per cent, 13.9 per cent and 5.1 per cent respectively. The Company's CholBiome products contains LP-LDL. Its products are commercialized in 60 countries. The CholBiome portfolio comprised four products, which can either be sold under the CholBiome brand or customers’ private labels: CholBiome, CholBiomeX3, CholBiomeBP and CholBiomeVH. CholBiome contains LPLDL to focus on healthy cholesterol maintenance and deliver tangible health benefits. CholBiomeX3 consists of LPLDL, Monacolin K from red yeast rice, and Vitamin B3 (niacin) to reduce cholesterol and aid overall cardiovascular health.
Contact details
Important dates
General stock information
- EPIC:
- PBX
- ISIN:
- GB00BLNBFR86
- Market cap:
- £10.68 million
- Shares in issue:
- 121.67 million
- Sector:
- Biotechnology
- Exchange:
- -
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.